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Abstract
This article summarizes the motivation for, and the proceedings of, the first ISA-TAB workshop held Decem-
ber 6–8, 2007, at the EBI, Cambridge, UK. This exploratory workshop, organized by members of the Microar-
ray Gene Expression Data (MGED) Society’s Reporting Structure for Biological Investigations (RSBI) working
group, brought together a group of developers of a range of collaborative systems to discuss the use of a com-
mon format to address the pressing need of reporting and communicating data and metadata from biological,
biomedical, and environmental studies employing combinations of genomics, transcriptomics, proteomics, and
metabolomics technologies along with more conventional methodologies. The expertise of the participants com-
prised database development, data management, and hands-on experience in the development of data com-
munication standards. The workshop’s outcomes are set to help formalize the proposed Investigation, Study,
Assay (ISA)-TAB tab-delimited format for representing and communicating experimental metadata. This arti-
cle is part of the special issue of OMICS on the activities of the Genomics Standards Consortium (GSC).
1
The OMICS Standards Scenario
THE MARRIAGE OF CONVENTIONAL METHODS with (meta)ge-nomics, transcriptomics, proteomics, and metabol/
nomics technologies (hereafter referred as “omics”) has cre-
ated not only opportunities, but also substantial new infor-
matics challenges. For example, consider the reporting of a
complex multiomic study looking at the effect on a number
of subjects of a compound inducing liver damage by char-
acterizing the metabolic profile of their urine (by mass spec-
troscopy), measuring protein and gene expression in the liver
(by mass spectrometry and DNA microarrays, respectively),
and conducting conventional histopathological analysis. To
coordinate the reporting of such a heterogeneous study re-
quires new approaches for communicating the complex
metadata (i.e., sample characteristics, study design, and ex-
ecution) required to correctly interpret the final results.
Many groups are rising to this challenge, and standards
for describing, formatting, submitting, and exchanging both
data and metadata from such complex studies are being de-
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veloped. Currently, several standards initiatives occupy
strategic positions in the international scenario, largely
falling into two groups identifiable by the needs of their re-
spective user communities. One group of initiatives is dri-
ven by regulatory frameworks, and most significantly, fo-
cuses on the Voluntary eXploratory Data Submissions
(VXDS) and electronic data submission programs of the Food
and Drug Administration (FDA) (Frueh, 2006; Tong et al.,
2007; U.S. HHS/FDA Guidance for Industry: Pharmacoge-
nomic data submissions, 2005). These initiatives include
long-standing efforts in the clinical and nonclinical domains
(http://www.cdisc.org/standards/index.html) alongside more
recent activities in the pharmacogenomics area, bringing the
added complexity of omics technologies to biomedical stud-
ies (Shabo, 2006). A second group of initiatives addressing
particular technologies or defined domains of application
have emerged from the academic community, and in many
cases benefit from the support of commercial organizations.
These initiatives are focused on supporting tool interoper-
ability and data exchange among public and proprietary sys-
tems, by developing common minimal requirements, for-
mats, and terminologies (Ball and Brazma, 2006; Deutsch et
al., 2008; Field and Sansone, 2006; Field et al., this issue; Le
Novère et al., 2005; Orchard and Hermjakob, 2007; Sansone
et al., 2007; Wiemann et al., community consultation).
Although we currently lack a global initiative ready to
bring these counterparts under one umbrella, among the aca-
demic community several synergistic activities have begun
that aim to foster the harmonization and consolidation of the
three kinds of standards being developed (checklists, syntax,
and semantics). More than 20 groups are now participating
in the Minimum Information for Biomedical or Biological In-
vestigations (MIBBI) project; set to be a one-stop shop for
those exploring the range of extant checklists and to foster
collaborative, integrative development (Taylor et al., 2008).
Several groups participate in the Functional Genomics
(FuGE) project to develop a single generic data model that
will underpin a variety of XML-based formats by providing
a single common framework (Jones et al., 2007). Over 60
groups participate in the Open Biological Ontology Foundry
(Smith et al., 2007, http://www.obofoundry.org), with the
objective of developing interoperable ontologies; and approx
20 communities are contributing to the creation of the On-
tology for Biomedical Investigation (OBI), which will sup-
port the description of experimental metadata in a stan-
dardized manner across a variety of biological and medical
domains. Managing this process of consensus-building from
start to finish takes time, resources, and expertise; the time
available to invest in finding commonalities and building
synergies among projects is limited due to lack of resources.
Lacking formal funding, developers participate on a volun-
tary basis, because the lack of standardization is an unac-
ceptable state of affairs for omics researchers, and is repeat-
edly proving to be a significant bottleneck in the collection,
sharing, and integration of data. The massively collaborative
nature of these undertakings mandates frequent face-to-face
workshops to create the necessary conditions for the build-
ing of consensus.
Rationale and Overview of the Workshop
This workshop is part of a series on omics data standards
funded by a Biotechnology and Biological Sciences Research
Council (BBSRC) award to the European Bioinformatics In-
stitute (EBI). These workshops are designed to (1) advance
the coordinated development of MIBBI, FuGE and OBI, (2)
identify stable subsets of those projects outputs that can be
implemented and tested, and (3) discuss interim solutions to
tackle today’s need for describing, formatting, submitting,
and exchanging both data and metadata while these syner-
gistic projects remain works in progress. The integrative el-
ements binding these themed workshops together are largely
informed by the opinions and requirements of the Report-
ing Structure for Biological Investigations (RSBI, http://
www.mged.org/Workgroups/rsbi) working group (San-
sone et al., 2006). RSBI was established in 2004 under the Mi-
croarray and Gene Expression Data (MGED) Society um-
brella (Ball and Brazma, 2006). RSBI has been conceived of
as a “single point of focus” for groups already independently
developing standards-supported databases and tools for bio-
logical, biomedical, and environmental studies employing
omics technologies and more conventional methodologies.
The goals of this workshop were twofold: first, to create
an “exchange network test bed,” of RSBI groups and other
collaborators that that have expressed an interest in lever-
aging on MIBBI, FuGE, and OBI; second, to evaluate a straw
man proposal addressing the pressing need for a format with
which to communicate study data and metadata while a
complete set of interoperable FuGE-based modules remains
a work in progress. The participants in this first workshop,
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TABLE 1. THE NODES OF THE “EXCHANGE NETWORK TEST BED” THAT
WERE REPRESENTED AT THE FIRST ISA-TAB WORKSHOP
System URL
ArrayExpress http://www.ebi.ac.uk/arrayexpress
ArrayTrack http://www.fda.gov/nctr/science/centers/toxicoinformatics
BioInvIndex http://www.ebi.ac.uk/net-project
CEBS http://cebs.niehs.nih.gov
Coral http://www.unilever.co.uk
GSC Genome Catalogue http://gensc.org/
Omixed http://www.omixed.org
PRIDE http://www.ebi.ac.uk/pride
Rosetta Resolver® http://www.rosettabio.com/products/resolver
Simbioms http://www.simbioms.org
SyMBA http://symba.sf.net
all of whom are authors of this article, included representa-
tives of public and proprietary repositories, and public and
commercial software developers (listed in Table 1), working
variously in academic, industrial and governmental groups
contributing to one or more standardization initiatives or to
the development of submission policies requiring the use of
reporting standards for omics-based data. In addition to
MIBBI, OBI, FuGE, and MGED, the Proteomics Standards
Initiative (PSI; Orchard and Hermjakob, 2007), the Meta-
bolomics Standards Initiative (MSI; Sansone et al., 2007), and
the Minimum Information About a Cellular Assay group
(MIACA; Wiemann et al., community consultation) (Table 2)
were represented at the meeting.
The workshop began with a welcome from the organizer,
Susanna-Assunta Sansone (EBI), who set the context for the
event; shortly followed by presentations of the MIBBI, FuGE,
and OBI projects, providing information on current status
and planned activities. For the second session, the meeting
participants provided brief overviews of their systems; to be
of most use, all had been asked to highlight where, in their
view, common standards could (potentially) bring benefits.
Weida Tong (NCTR-FDA), who cochaired the workshop,
gave an overview of the Study Data Tabulation Model
(STDM, http://www.cdisc.org/standards/index.html) and
that format’s requirements and challenges in the context of
VXDS submissions to the FDA. A few themes emerged from
the presentations; the most important being the need for a
simple format to submit or exchange studies employing
omics technologies along with more conventional method-
ologies, while a complete set of interoperable XML modules,
such as FuGE-based community formats, are still under de-
velopment. The Investigation/Study/Assay (ISA) tab-de-
limited (TAB) format was then presented by Philippe Rocca-
Serra (EBI) as a straw man proposal in the third session,
which was followed by open discussion.
Overall, this first exploratory workshop produced general
consensus around the ISA-TAB proposal, and in addition, a
clear work plan to refine and test it further. The next sec-
tions provide a brief overview of the ISA-TAB proposal and
present the heterogeneous group of nodes participating in
the “exchange network test bed” (Table 1).
ISA-TAB in a Nutshell
Investigation, Study, and Assay are the three key entities
(Sansone et al., 2006) around which the ISA-TAB framework
is built; these assist in structuring metadata and describing
the relationship of samples to data (Fig. 1). The ISA-TAB pro-
posal builds on the successful uptake of the MicroArray
Gene Expression (MAGE) TAB format, which supports the
management, exchange and submission of microarray-based
experiment data and metadata (Rayner et al., 2006). MAGE-
TAB was designed for use by laboratories with little or no
bioinformatics support, rendering them unable to deal with
the complexity of MAGE Markup Language (ML) formatted
files (Spellman et al., 2002), which often are also exception-
ally large—too large to be easily read by most people, and
often too large to be read by most software programs (Maier
et al., 2008). ISA-TAB can be viewed as an extended version
of the MAGE-TAB paradigm, sharing its motivation for the
use of tab-delimited text files; that is, that they can be cre-
ated programmatically or by using spreadsheet software
such as Microsoft Excel, where they can easily be viewed and
edited by researchers. Like MAGE-TAB before it, ISA-TAB
is simply a format with which to communicate information.
Neither minimum requirements nor the use of controlled ter-
minologies are within the scope of this proposal. Therefore,
the decision on how to regulate its use (e.g., by enforcing
MIBBI minimum requirements, or mandating the use of OBO
Foundry terminologies) is solely a matter for those who will
implement the format in their system. The ISA-TAB actually
employs MAGE-TAB syntax to ensure backward compati-
bility with existing MAGE-TAB files, to facilitate the future
adoption of one common format. However, ISA-TAB has a
number of additional features making it a more general
framework that can capture the complexity of studies em-
ploying a combination of technologies. For example, where
omics-based technologies are being used in clinical or non-
clinical studies, ISA-TAB can complement existing biomed-
ical formats such as the SDTM by formally capturing infor-
mation about the interrelationship of the various parts.
It is important to maintain an alignment between the con-
cepts in ISA-TAB and (some of) the objects in the FuGE
model, partly as that model is integral to the development
of MAGE-ML v2. The ISA-TAB format could be seen as com-
peting with XML-based formats, whether existing or under
development, such as the FuGE-ML. However, ISA-TAB ad-
dresses an immediate need, whereas a complete set of FuGE-
based modules or other interoperable XML is still some way
off. Once such formats do become available, ISA-TAB can
continue to serve those with little or no bioinformatics sup-
port, as well as finding utility as a user-friendly presentation
layer for XML-based formats (via an XSL transformation);
that is, in the manner of the HTML rendering of MAGE-ML
documents (http://www.ebi.ac.uk/,rocca/MAGE-XSLT/
HTML%20rendering%20of%20MAGE.htm).
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TABLE 2. THE STANDARDIZATION INITIATIVES THAT WERE REPRESENTED
AT THE FIRST ISA-TAB WORKSHOP
Initiative URL Domain
GSC http://gensc.org Genomics
MGED http://www.mged.org Transcriptomics
MIACA http://miaca.sourceforge.net Cellular assay
MSI http://msi-workgroups.sourceforge.net Metabolomics
PSI http://www.psidev.info Proteomics
FuGE http://fuge.sf.net Generic data model
MIBBI http://mibbi.sf.net Modular checklists
OBI http://obi.sf.net Common terminology
For the development of this format, openness and due pro-
cess must apply. To ensure that all groups have access to in-
formation, a public Web site has been created at SourceForge
(http://isatab.sourceforge.net). It contains the latest ISA-TAB
v0.2 specification, an alignment with MAGE-TAB, the list of
participants and their systems and a link to a mailing list to
which interested parties can subscribe. Several example ISA-
TAB “instance” files are being created from published bio-
logical, biomedical, and environmental studies, to be posted
on the Web site. For example, the first was created by mem-
bers of the Genomics Standards Consortium (GSC) (Field et
al., 2008, this issue) using a dataset published by Gilbert et
al. (2008) originating from a joint metagenomics and meta-
transcriptomics study looking at the effect of ocean acidifi-
cation on phytoplankton and bacterioplankton.
The Exchange Network Test Bed
The initial motivation for creating the ISA-TAB straw man
proposal was to meet the needs of the BioInvestigation In-
dex (BioInvIndex) system at EBI (Table 1). BioInvIndex aims
to create a common structured representation of the meta-
data and the sample-data relationship for biological, bio-
medical, and environmental studies employing omics-based
technologies along with more conventional methodologies.
The ISA-TAB format is being developed to assist users make
combined submissions to EBI public archives; for example,
to ArrayExpress, PRIDE and a metabolomics repository to
be developed in the near future. It has been clear from the
outset that the ISA-TAB framework could also serve as a
common crossplatform format, thereby greatly benefiting
other collaborators; to pipeline omics-based experimental
data into EBI public repositories, to enable their users to im-
port data from EBI repositories into their local systems, or
simply to exchange data among themselves. Therefore, in a
collaborative spirit the development of the ISA-TAB has been
opened up and shared with a wider community.
The section below provides a brief overview of the col-
laborative systems whose developers constitute the nodes of
this “exchange network test bed” for ISA-TAB format.
ArrayExpress is the EBI public resource for microarray
and transcriptomics data (Parkinson et al., 2007); it supports
the Minimum Information About a Microarray Experiment
standard (MIAME; Brazma et al., 2001). The system consists
of two parts: the ArrayExpress repository, which is one of
the databases recommended by the MGED Society for
archiving publication-related microarray data, and the ware-
house of gene expression profiles, which uses the data in the
repository. ArrayExpress supports all MGED standards and
recommendations; it accepts and distributes data in the
MAGE-TAB format. ArrayExpress will ultimately use the
ISA-TAB format, it being a generalization of MAGE-TAB.
ArrayTrack is a publicly available FDA genomic tool that
has been used for the FDA review of genomic data submis-
sions (Tong et al., 2004, 2007). It provides an integrated so-
lution for managing, analyzing, and interpreting microarray
gene expression data. ArrayTrack is MIAME supportive for
storing both microarray data and experiment parameters as-
sociated with a pharmacogenomics or toxicogenomics study.
However, recently the FDA has encountered multiomic data
sets, submitted by industry as part of the VXDS program.
The ISA-TAB crossplatform standard can be used to manage
multiomic data in ArrayTrack, and additionally, provides a
means to communicate multiomic data between ArrayTrack
and other software platforms.
CEBS is the Chemical Effects in Biological Systems, an in-
tegrated public repository for toxicologic and toxicoge-
nomics data, including the study design and timeline, clini-
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The Study file contains
contextualizing
information for one or
more assays; i.e., the
subjects studied, their
source(s), the sampling
methodology, their
characteristics, and any
treatments or
manipulations performed
to prepare the specimens.
The Assay file contains
information about a certain
set (or type) of assays,
defined by the endpoint
measured (i.e., gene
expression) and the
technology employed (i.e.,
DNA microarray), including
information on protocols,
additional information in
part relating to the
execution of those protocols
and references to data files
All Data files resulting from
assays, including raw data
files, processed and normalized
data files.  For DNA gene
expression assays employing
microarray technology, the set
of data files, should include an
Array Description File (ADF)
and a Final Gene Expression
Data Matrix (FGDM), as
required by the MAGE-TAB
specification.
The Investigation file
• records all declarative
information referenced
in the other files such as
contacts, protocols and
equipment;
• relates Assay files to
Study files;
• relates Study files to an
Investigation (only when
two or more Study files
exist, as in this example).
Study 1
Study 2
Assay(s)
ISArchive
Assay(s)
Data
Data
Investigation
FIG. 1. An overview of the ISA–TAB struc-
ture is shown here; for submission or transfer,
files can be packaged into an ISArchive. De-
tailed description of each file is available in 
the ISA-TAB v0.2 specification (http://isatab.
sourceforge.net).
cal chemistry and histopathology findings, and microarray
and proteomics data. CEBS contains modules for the study
component of each investigation, and stores data in data-
type specific modules. The system permits users to explore
data by integrating across studies and across data modules,
and then either to download or to analyze the data of inter-
est within CEBS. To facilitate the publication, exchange and
reuse of data the system is engaged in developing tools for
depositors and annotation formats for study data and meta-
data. The development of ISA-TAB is an important part of
this effort.
Coral is an investigation-centric data management system
used within Unilever’s Safety and Environment Assurance
Centre (SEAC). The system has to be able to capture de-
scriptions of complex scientific investigations, allowing the
linkage of a single sample to multiple analyses employing
various assays. Key to Coral’s success was that it can be read-
ily configured for new assays (transcriptomic, proteomic,
etc.) and sample types, making it robust to both technolog-
ical developments and new experimental designs. When
configuring Coral for new data types, it is imperative that it
conforms to community standards, so that data can be ex-
changed with external systems. Therefore, established stan-
dards such as MIAME and the Minimum Information About
a Proteomics Experiment (MIAPE; Taylor et al., 2007) are
used (Brazma et al., 2001; Taylor et al., 2007), in addition to
emerging standards in the metabolomics domain (Sansone
et al., 2007). ISA-TAB will allow the system to better define
the essential meta-information that it should capture from
investigation and assay types not previously encountered, in
order to ensure interoperability with other ISA-TAB com-
pliant systems.
The GSC’s Genome Catalog is a pilot online repository for
holding case studies that have helped the development of its
Minimum Information about a Genome Sequence (MIGS)
specification (Field et al., 2008). This database is now also
serving as a repository for collected information. Input of
data is currently managed through a set of web forms, but
this only serves the needs of genome and metagenome au-
thors with one or two projects to register. For users with
more, submission of data should be tackled programmati-
cally; to that end an XML implementation of MIGS is being
developed (Kottmann, 2008). For those users who do not
want to use XML, or cannot easily do so, a spreadsheet based
submission format would be ideal. Therefore, the GSC is con-
tributing to the development of ISA-TAB as it greatly prefers
to work with the international community in a multiomic
context rather than build a GSC-specific solution.
Omixed is a software system designed to manage scien-
tific research data using an intuitive, Web-based interface.
Omixed is developed by the Natural Environmental Re-
search Council’s Environmental Bioinformatics Center
(NEBC; http://nebc.nox.ac.uk) to serve the needs of a large
user base of interconnected labs throughout the UK who are
engaged in environmental research. This system allows the
collection and management of multiomic data in a robust,
secure, and collaborative manner. NERC strongly supports
the use of international standards and promotes long-term
data storage; therefore, it is a firm requirement that Omixed
facilitate convenient, standardized data capture, support in-
tegrative data analyses, and enable the publication of data
sets to public repositories. The ISA-TAB format will allow
Omixed users to submit and import studies to and from other
compliant systems.
PRIDE is the Proteomics IDEntifications Database, a
repository of identifications of proteins, peptides, and pro-
tein modifications by mass spectrometry (Jones et al., 2008).
The vast majority of data in PRIDE originate from direct sub-
missions; however, the complexity of the XML format de-
scribing a complete PRIDE experiment places a significant
burden on laboratories with limited bioinformatics support.
The PRIDE Proteome Harvest Data Submission Spreadsheet
(http://www.ebi.ac.uk/pride/proteomeharvest/index.html),
which allows a PRIDE submission to be constructed in a tab-
ular format, helps to resolve this problem, and has proven
popular with PRIDE data submitters. The creation of a gen-
eral solution such as ISA-TAB for the submission of pro-
teomics data (under the wider umbrella of omics in general)
will therefore benefit both the PRIDE project and the com-
munity that it supports.
Rosetta Resolver® Gene Expression Analysis System is a
comprehensive, flexible gene expression data analysis, man-
agement, and storage environment developed by Rosetta
Biosoftware. The system allows for automated data import
from multiple array technologies, including those manufac-
tured by Affymetrix®, Agilent®, and Illumina®. The Resolver
system supports multiple data standards such as CDISC/
SEND and MAGE-ML, and is MIAME-compliant. MAGE-
ML allows the Resolver system to import and export data
from multiple Resolver clients, as well as from external soft-
ware applications. The Resolver system also supports FDA
Code of Federal Regulations (21 CFR Part 11, 2000) compli-
ance as validated by industry audits, and data exchange be-
tween internal or external collaborators (including with the
FDA in a variety of formats). ISA-TAB has the potential to
be a crossplatform standard that can be easily parsed and
written by the Resolver system.
Simbioms is the System for Information Management in
Biomedical Studies, a lightweight open source software
package for managing biomedical research data. The system,
originally developed for a large international genetic epi-
demiology project, is Web based and can be run either on a
central server for collaborative projects, or on a researcher’s
PC. It consists of two components: The Patient and Sample
System for Information Management (PASSIM) (Viksna et
al., 2007), and Assay and Data Management System (AIMS).
It is customized for a wide range of high throughput tech-
nologies and applications including genotyping. The system
can import and export data in tab-delimited format and will
be made fully compliant with ISA-TAB once the standard is
finalized.
SyMBA is the Systems and Molecular Biology Data and
Metadata Archive, comprising a versioned database, a Java
toolkit, and a Web front-end, all based on the FuGE-OM.
SyMBA archives, stores, and retrieves raw high-throughput
data and metadata in a single database. Originally developed
to meet the needs of an interdisciplinary systems biology
center, it is now an open-source, multideveloper project
available from SourceForge. Making use of community data
standards such as FuGE, SyMBA reduces development time
while simultaneously increasing compatibility with other
data providers. A format such as ISA-TAB would enable
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SyMBA users to submit their FuGE-formatted data and
metadata to the EBI public databases until direct FuGE sub-
mission becomes available.
Conclusions and Next Steps
This first exploratory workshop produced a general con-
sensus on the ISA-TAB proposal and on the importance of
having (1) a simple format that can easily be created, viewed,
and edited by researchers with little or no bioinformatics
support, and (2) a common user-friendly presentation layer
for (interoperable) XML-based formats, once a complete set
of such formats becomes available. The attendees agreed that
follow-up meetings to coordinate developmental activity
would be needed. Funding for future workshops has been
secured by the BBSRC award to EBI with contributions from
NERC’s NEBC and the GSC. The next workshop is planned
for June 16–18, 2008, at the EBI; on that occasion ISA-TAB
v0.2 will be examined in the light of a series of real case ex-
amples being produced by the participating communities,
and will be revised as necessary. The agenda will also in-
clude a discussion on, and examples of the kinds of imple-
mentations and tools (that need to be) developed to assist
users create ISA-TAB files. Documentation will be finalized
and a manuscript drafted; the intent being to publish it as
an open access paper. Anyone interested in knowing more
about or joining this effort is encouraged to subscribe to the
mailing list.
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